Skip to content

Clinical trials

Phase 2 Endometrial Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 2 Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20161
20193
20211
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Canadian Cancer Trials Group1
Daiichi Sankyo1
European Organisation for Research and Treatment of Cancer - EORTC1
Frederic Amant1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Leiden University Medical Center1
Millennium Pharmaceuticals, Inc.1
Radboud University Medical Center1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms11
Uterine Neoplasms3
Esophageal Neoplasms2
Ovarian Neoplasms2
Stomach Neoplasms2
Urinary Bladder Neoplasms2
Uterine Cervical Neoplasms2
Breast Neoplasms1
Carcinoma1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.